IFNA2 and cancer: To understand the dynamic upregulation of TRAIL by IFNα in the different cancer types, we examined the genomic regulatory landscape to unravel the gene regulatory architecture (i.e., accessible chromatin carrying either disperse enhancers or enhancer clusters).